2026 NPPES data Procedural Dermatology Physician NPI 1124015318 M.D.
Verify on CMS →

ALAN GLASS, M.D.

Procedural Dermatology Physician in INWOOD, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
344
Medicare Part D claims · 122 beneficiaries · Procedural Dermatology Physician avg: 664
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$3.2K
142 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ALAN GLASS, M.D. is a Procedural Dermatology Physician ([object Object]) practicing in INWOOD, New York with a Medicare Part D prescribing footprint of 344 claims across 122 beneficiaries — 15% brand-name prescribing . Industry payments of $3.2K across 142 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ALAN GLASS, M.D. filed 344 Medicare Part D claims in 2023 across INWOOD, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

ALAN GLASS, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

ALAN GLASS, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 10/03/2005

NPI 1124015318

Primary specialty

Procedural Dermatology Physician

Niche

679 US NPIs in this specialty

Medicare Part D claims

344 48% vs specialty avg

2023 prescription claims

Specialty avg: 664

Specialty distribution in New York

How Procedural Dermatology Physician compares to other specialties among New York providers

New York providers

Procedural Dermatology Physician share within New York

1. Procedural Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Procedural Dermatology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Procedural Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Procedural Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Procedural Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Procedural Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALAN GLASS, M.D. is a Procedural Dermatology Physician provider practicing in INWOOD, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1124015318. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ALAN GLASS, M.D. appears in the CMS NPPES registry as a Procedural Dermatology Physician provider holding M.D. credentials at 271 DOUGHTY BLVD, INWOOD, NY, 11096, with a listed phone of (516) 239-4244. NPI 1124015318 was issued on 10/03/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GLASS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 344 prescription claims written by this provider, covering 122 Medicare beneficiaries and totaling roughly $99K in drug spend, split 15% brand-name and 85% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Procedural Dermatology Physician is a narrow specialty nationwide, with 679 enrolled providers across 48 states and an average of 664 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

271 DOUGHTY BLVD
INWOOD, NY 11096

Provider Details

NPI 1124015318
Specialty Procedural Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 10/03/2005

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALAN GLASS, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$3.2K

Largest payer

GENZYME CORPORATION

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ALAN GLASS, M.D.. To verify ALAN GLASS, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ALAN GLASS, M.D. — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 344 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

344
Total Claims
$99K
Total Drug Cost
122
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
396
Total Day Supply
9,946
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$86K
Generic Drug Cost
$13K
Antibiotic Claims
13

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
0.85
Gender Split
47% female / 53% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Mupirocin
44
Ciclopirox
Ciclopirox Olamine
33
Valacyclovir
Valacyclovir Hcl
29
Hydrocortisone
25
Mometasone Furoate
19
Betamethasone Dipropionate
14
Fluocinolone Acetonide
14
Triamcinolone Acetonide
14
Metronidazole
11
Otezla
Apremilast
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Procedural Dermatology Physician Overview

How ALAN GLASS, M.D. fits within the Procedural Dermatology Physician landscape nationally.

679
Procedural Dermatology Physician Providers in US
48
States with Procedural Dermatology Physician
664
Avg Claims per Provider

ALAN GLASS, M.D.'s 344 claims are below the specialty average of 664.

Nearby Procedural Dermatology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GLASS.

Compare Procedural Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALAN GLASS, M.D.'s specialty?
ALAN GLASS, M.D. specializes in Procedural Dermatology Physician and practices in INWOOD, New York. Credentials: M.D..
How much does ALAN GLASS, M.D. prescribe under Medicare Part D?
In 2023, ALAN GLASS, M.D. wrote 344 Medicare Part D claims totaling $99K in drug costs for 122 beneficiaries.
Where is ALAN GLASS, M.D. located?
ALAN GLASS, M.D. is located at 271 DOUGHTY BLVD, INWOOD, NY, 11096. Phone: (516) 239-4244.
What is ALAN GLASS, M.D.'s NPI number?
ALAN GLASS, M.D.'s National Provider Identifier (NPI) is 1124015318, issued on 10/03/2005.
Does ALAN GLASS, M.D. prescribe more brand-name or generic drugs?
ALAN GLASS, M.D.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $86K in brand drug costs.
How many Procedural Dermatology Physician providers are there in the US?
There are 679 Procedural Dermatology Physician providers across 48 states in the US. The average Procedural Dermatology Physician provider writes 664 Medicare Part D claims per year.
What drugs does ALAN GLASS, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ALAN GLASS, M.D.'s most frequently prescribed drugs include Mupirocin, Ciclopirox, Valacyclovir. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALAN GLASS, M.D. accept Medicare?
ALAN GLASS, M.D. appears in CMS Medicare data with 344 Part D claims and 122 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALAN GLASS, M.D.'s credentials?
ALAN GLASS, M.D.'s NPI is 1124015318 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology